Please wait while the formulary information is being retrieved.
MELPHALAN HCL (MELPHALAN HCL)
- Conditioning prior to autologous stem cell transplant
- Multiple myeloma
- Melphalan Iv Solution
- Melphalan Intravenous Solution
- Evomela Intravenous Solution
- Alkeran Intravenous Solution
- Alkeran (as Hcl) Intravenous Solution
- By Indication
50 mg intravenous solution
- Infuse 16 mg/m2 over 15-20 minute(s) by intravenous route every 4 weeks
melphalan 50 mg intravenous solution
- Infuse 16 mg/m2 over 15-20 minute(s) by intravenous route every 4 weeks
50 mg intravenous solution
- Infuse 16 mg/m2 over 15-20 minute(s) by intravenous route every 4 weeks
(as HCl) 50 mg intravenous solution
- Infuse 16 mg/m2 over 15-20 minute(s) by intravenous route every 4 weeks
(as HCl) 50 mg intravenous solution
- Infuse 16 mg/m2 over 15-20 minute(s) by intravenous route every 4 weeks
Conditioning prior to autologous stem cell transplant
- Infuse 100 mg/m2 over 30 minute(s) by intravenous route for 2 consecutive days (days 2 and 3) prior to transplantation
Multiple myeloma
- Infuse 16 mg/m2 over 15-20 minute(s) by intravenous route every 4 weeks
- Infuse 16 mg/m2 over 15-20 minute(s) by intravenous route every 2 weeks for 4 doses
- adenovirus vac live type-4 & 7
- adenovirus vaccine live type-4
- adenovirus vaccine live type-7
- BCG vaccine, live (PF)
- flu vac,qval 2013-14 (2-49yrs)
- Flumist 2013-2014
- M-m-r Ii (pf)
- measles,mumps&rubella vacc(PF)
- measles,mumps,rub,varicel(PF)
- natalizumab
- Proquad (pf)
- Rotateq Vaccine
- rotavirus vaccine live, penta
- typhoid vaccine
- Tysabri
- varicella virus vacc live (PF)
- Varivax (pf)
- Vivotif Berna Vaccine
- yellow fever vaccine live (PF)
- Yf-vax (pf)
- Zostavax (pf)
- zoster vaccine live (PF)
Contraindicated
- clozapine
- Clozaril
- deferiprone
- Fazaclo
- Ferriprox
- Versacloz
Severe
Moderate
- None
- Drug-induced hepatitis
- Hemolytic anemia
- Hepatic veno-occlusive disease
- Interstitial pneumonitis
- Lactating mother
- Pulmonary fibrosis
- Severe infection
Contraindicated
- Anemia
- Bone marrow depression
- Granulocytopenic disorder
- Hemorrhage
- Kidney disease with reduction in GFR
- Leukopenia
- Pregnancy
- Thrombocytopenic disorder
- Vasculitis
Severe
Moderate
- Abnormal hepatic function tests
MELPHALAN HCL (MELPHALAN HCL)
- Conditioning prior to autologous stem cell transplant
- Multiple myeloma
- Anemia
- Bone marrow depression
- Infection
- Leukopenia
- Neutropenic disorder
- Thrombocytopenic disorder
- None
More Frequent
Severe
Less Severe
- Allergic dermatitis
- Anaphylaxis
- Pruritus of skin
- Skin rash
- Alopecia
- Diarrhea
- Nausea
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Acute myeloid leukemia
- Dermal necrosis
- Extravasation injury
- Hepatic veno-occlusive disease
- Hepatitis
- Hyperuricemia
- Interstitial pneumonitis
- Obstructive hyperbilirubinemia
- Pulmonary fibrosis
- Stomatitis
- Urticaria
- Vasculitis
Less Severe
- Amenorrhea
- Sensation of warmth
Contraindicated
None
Severe Precaution
Melphalan
Risk of severe bone marrow depression. No established safety and efficacy.
- 1 Day – 13 Years
- Risk of severe bone marrow depression. No established safety and efficacy.
Management or Monitoring Precaution
None
Melphalan
- Severity Level:
D
- Additional Notes: Based on drug pharmacology dev tox may occur; animal data sug dev tox
Contraindicated
Melphalan
Not recommended, risk of severe toxicity.
General | Excretion Potential | Effect on Infant | Notes |
Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Not recommended, risk of severe toxicity. |
Precaution Exists
None
General | Excretion Potential | Effect on Infant | Notes |
None |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- Although melphalan is used to treat cancer, it may rarely increase your risk of developing other cancers. Also, melphalan may cause a severe decrease in your blood cells, which lowers your ability to fight infections and increases the risk of anemia/bleeding problems. You may be more likely to get a serious (rarely fatal) infection or any infection you have may get worse.<br /><br /> Tell your doctor right away if you develop unusual growths or lumps, swollen glands, signs of infection (such as a sore throat that doesn't go away, fever, chills), easy or unusual bruising/bleeding, or unusual tiredness. Melphalan may cause a serious allergic reaction. Get medical help right away if you develop rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, or trouble breathing.
Multiple myeloma | |
C90.0 | Multiple myeloma |
C90.00 | Multiple myeloma not having achieved remission |
C90.02 | Multiple myeloma in relapse |
0-9 | A-Z |
---|---|
C90.0 | Multiple myeloma |
C90.00 | Multiple myeloma not having achieved remission |
C90.02 | Multiple myeloma in relapse |
Formulary Reference Tool